September 24th, 2021
Center for Advancing Point of Care Technologies (CAPCaT) awarded Respira Labs with a $110K grant

The Center for Advancing Point of Care Technologies (CAPCaT) is a new initiative run by the Massachusetts Medical Device Development Center (M2D2), a joint partnership between UMass Lowell and UMass Medical School and supported by the National Institutes of Health, which assist inventors pioneering promising new point-of-care devices and technologies for patients with heart, lung, blood and sleep disorders.

This time, Respira Labs was chosen from 103 applicants in the US (three winners, all female and latino led) to receive a $110K prize awarded by CAPCaT, making this their 4th grant in less than two years. Not to mention the opportunity to benefit from the expertise of scientists, business developers, and legal experts, as well as the resources available at UMass Lowell and UMass Medical School, facilitating the development of new technologies to help clinicians and health care systems deliver higher quality care at a lower cost.

Respira Labs is very grateful for all the support, make sure to sign up for more updates.